- Title
- First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
- Creators
- Linda M. Liau - University of California, Los AngelesKeyoumars Ashkan - King's College LondonDavid D. Tran - University of FloridaJian L. Campian - Washington University in St. LouisJohn E. Trusheim - Abbott Northwestern HospitalCharles S. Cobbs - Seattle, WA USAJason A. Heth - University of Michigan–Ann ArborMichael Salacz - University of KansasSarah Taylor - University of KansasStacy D. D’Andre - Sacramento, CA USAFabio M. Iwamoto - Columbia University Irving Medical CenterEdward J. Dropcho - Indiana UniversityYaron A. Moshel - Overlook Medical CenterKevin A. Walter - University of Rochester Medical CenterClement P. Pillainayagam - Rush University Medical CenterRobert Aiken - Rutgers, The State University of New JerseyRekha Chaudhary - University of CincinnatiSamuel A. Goldlust - Hackensack University Medical CenterDaniela A. Bota - University of California, IrvinePaul Duic - Winthrop-University HospitalJai Grewal - Mineola, NY USAHeinrich Elinzano - Rhode Island HospitalSteven A. Toms - Rhode Island HospitalKevin O. Lillehei - University of Colorado HospitalTom Mikkelsen - Henry Ford Health SystemTobias Walbert - Henry Ford Health SystemSteven R. Abram - St. Thomas Research Institute, Nashville, TN USAAndrew J. Brenner - The University of Texas Health Science Center at San AntonioSteven Brem - University of PennsylvaniaMatthew G. Ewend - University of North Carolina at Chapel HillSimon Khagi - University of North Carolina at Chapel HillJana Portnow - City Of Hope National Medical CenterLyndon J. Kim - Thomas Jefferson UniversityWilliam G. Loudon - St. Joseph HospitalReid C. Thompson - Vanderbilt UniversityDavid E. Avigan - Beth Israel Deaconess Medical CenterKaren L. Fink - Baylor University Medical CenterFrancois J. Geoffroy - Peoria, IL USAScott Lindhorst - Medical University of South CarolinaJose Lutzky - Mount Sinai HospitalAndrew E. Sloan - Cleveland, OH USAGabriele Schackert - TU DresdenDietmar Krex - TU DresdenHans-Jorg Meisel - BG Klinikum Bergmannstrost HalleJulian Wu - Tufts UniversityRaphael P. Davis - Stony Brook UniversityChristopher Duma - NewportArnold B. Etame - Tampa, FL USADavid Mathieu - Université de SherbrookeSantosh Kesari - University of California, San DiegoDavid Piccioni - University of California, San DiegoManfred Westphal - Hamburg, GermanyDavid S. Baskin - Houston MethodistPamela Z. New - Houston MethodistMichel Lacroix - Geisinger Health SystemSven-Axel May - Chemnitz, GermanyTimothy J. Pluard - Kansas City, MO USAVictor Tse - Kaiser PermanenteRichard M. Green - Kaiser PermanenteJohn L. Villano - University of KentuckyMichael Pearlman - Englewood, CO USAKevin Petrecca - Montreal Neurological Institute and HospitalMichael Schulder - Hofstra UniversityLynne P. Taylor - University of WashingtonAnthony E. Maida - Northwest BiotherapeuticsRobert M. Prins - University of California, Los AngelesTimothy F. Cloughesy - University of California, Los AngelesPaul Mulholland - London, UKMarnix L. Bosch - Northwest Biotherapeutics
- Publication Details
- Journal of translational medicine, Vol.16(1), pp.1-142
- Publisher
- BioMed Central
- Academic Unit
- Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
- Language
- English
- Resource Type
- Journal article
- PMID
- 29843811
- PMCID
- PMC5975654
- Record Identifier
- 991031713880902976
Journal article
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
Journal of translational medicine, Vol.16(1), pp.1-142
2018-05-29
PMCID: PMC5975654
PMID: 29843811
Metrics
2 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
Highly Cited Paper
- Collaboration types
- Domestic collaboration
- International collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.113 Brain Imaging
- 1.113.453 Glioblastoma
- Web Of Science research areas
- Medicine, Research & Experimental
- ESI research areas
- Clinical Medicine
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites